אפרקס 20000 Israel - hebreu - Ministry of Health

אפרקס 20000

j-c health care ltd - erythropoietin human recombinant - תמיסה להזרקה - erythropoietin human recombinant 20000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat

אפרקס 30000 Israel - hebreu - Ministry of Health

אפרקס 30000

j-c health care ltd - erythropoietin human recombinant - תמיסה להזרקה - erythropoietin human recombinant 30000 iu / 0.75 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) orb: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicate

רטרוביר קפסולות 100 מג Israel - hebreu - Ministry of Health

רטרוביר קפסולות 100 מג

glaxo smith kline (israel) ltd - zidovudine - קפסולות - zidovudine 100 mg - zidovudine - zidovudine - retrovir oral formulations are indicated in anti-retroviral combination therapy for human immunodeficiency virus (hiv) infected adults and children.retrovir chemoprophylaxis is indicated for use in hiv-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal hiv transmission and for primary prophylaxis of hiv infection in newborn infants.

רטרוביר קפסולות 250 מג Israel - hebreu - Ministry of Health

רטרוביר קפסולות 250 מג

glaxo smith kline (israel) ltd - zidovudine - קפסולות - zidovudine 250 mg - zidovudine - zidovudine - retrovir oral formulations are indicated in anti-retroviral combination therapy for human immunodeficiency virus (hiv) infected adults and children.retrovir chemoprophylaxis is indicated for use in hiv-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal hiv transmission and for primary prophylaxis of hiv infection in newborn infants.

רטרוביר לאינפוזיה תוך ורידית Israel - hebreu - Ministry of Health

רטרוביר לאינפוזיה תוך ורידית

glaxo smith kline (israel) ltd - zidovudine - תמיסה לאינפוזיה - zidovudine 200 mg / 20 ml - zidovudine - zidovudine - retrovir iv for infusion is indicated for the short term management of serious manifestations of human immunodeficiency virus (hiv) infection in patients with acquired immuno deficiency syndrome (aids) or aids related complex (arc) who are unable to take retrovir oral formulations.

למיבודין  זידובודין טבע   150 מג  300 מג Israel - hebreu - Ministry of Health

למיבודין זידובודין טבע 150 מג 300 מג

abic marketing ltd, israel - lamivudine as anhydrous; zidovudine - טבליה - zidovudine 300 mg; lamivudine as anhydrous 150 mg - zidovudine - zidovudine - antiretroviral combination therapy for the treatment of hiv infected adults and adolescents over the age of 12 years.

אפיביר 150 מג Israel - hebreu - Ministry of Health

אפיביר 150 מג

glaxo smith kline (israel) ltd - lamivudine - טבליות מצופות פילם - lamivudine 150 mg - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.

קומביויר Israel - hebreu - Ministry of Health

קומביויר

glaxo smith kline (israel) ltd - lamivudine; zidovudine - טבליות מצופות פילם - lamivudine 150 mg; zidovudine 300 mg - lamivudine - lamivudine - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.

אפיביר תמיסה לשתיה Israel - hebreu - Ministry of Health

אפיביר תמיסה לשתיה

glaxo smith kline (israel) ltd - lamivudine - תמיסה (פומי) - lamivudine 10 mg/ml - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.

אפיביר 300 מג Israel - hebreu - Ministry of Health

אפיביר 300 מג

glaxo smith kline (israel) ltd - lamivudine - טבליות מצופות פילם - lamivudine 300 mg - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.